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Abstract
Background: Selection for increasing intramuscular fat content would definitively improve the palatability and 
juiciness of pig meat as well as the sensorial and organoleptic properties of cured products. However, evidences 
obtained in human and model organisms suggest that high levels of intramuscular fat might alter muscle lipid and 
carbohydrate metabolism. We have analysed this issue by determining the transcriptomic profiles of Duroc pigs with 
divergent phenotypes for 13 fatness traits. The strong aptitude of Duroc pigs to have high levels of intramuscular fat 
makes them a valuable model to analyse the mechanisms that regulate muscle lipid metabolism, an issue with evident 
implications in the elucidation of the genetic basis of human metabolic diseases such as obesity and insulin resistance.
Results: Muscle gene expression profiles of 68 Duroc pigs belonging to two groups (HIGH and LOW) with extreme 
phenotypes for lipid deposition and composition traits have been analysed. Microarray and quantitative PCR analysis 
showed that genes related to fatty acid uptake, lipogenesis and triacylglycerol synthesis were upregulated in the 
muscle tissue of HIGH pigs, which are fatter and have higher amounts of intramuscular fat than their LOW counterparts. 
Paradoxically, lipolytic genes also showed increased mRNA levels in the HIGH group suggesting the existence of a cycle 
where triacylglycerols are continuously synthesized and degraded. Several genes related to the insulin-signalling 
pathway, that is usually impaired in obese humans, were also upregulated. Finally, genes related to antigen-processing 
and presentation were downregulated in the HIGH group.
Conclusion: Our data suggest that selection for increasing intramuscular fat content in pigs would lead to a shift but 
not a disruption of the metabolic homeostasis of muscle cells. Future studies on the post-translational changes 
affecting protein activity or expression as well as information about protein location within the cell would be needed 
to to elucidate the effects of lipid deposition on muscle metabolism in pigs.
Background
Muscle lipid metabolism affects a wide diversity of meat
quality traits that are of huge importance for the pig
industry [1]. Intramuscular fat percentage is favourably
associated with meat texture, tenderness, flavour and
juiciness [2,3]. In addition, muscle fat composition has a
strong effect on the sensorial, nutritional and technologi-
cal properties of meat [1]. The proportion of monounsat-
urated fatty acids (mainly oleic) is a key factor
determining meat fat consistency and taste [1], whereas
polyunsaturated fatty acids have a marked tendency to be
oxidized, producing a rancid odour and taste that
decrease meat consumer's acceptance. From a human
health perspective, increased amounts of polyunsatu-
rated fatty acids in the diet diminish the susceptibility to
suffer cardiovascular diseases, while saturated fatty acids
have the opposite effect [4].
Selection for higher muscle fat content and composi-
tion might have a long-term impact on pig muscle physi-
ology that has not been evaluated yet. For instance, in
obese humans, accumulation of triacylglycerols in the
myocyte is associated with the development of insulin
resistance, metabolic syndrome and type II diabetes [5,6].
In this way, increases in skeletal muscle fat stores are
often accompanied by a parallel reduction in the β-oxida-
tion of fatty acids and the progressive accumulation of
lipid metabolites, such as diacylglycerol and long-chain
acyl-CoAs, which impair insulin-stimulated glucose
transport [5,6]. Although selection for increased intra-
muscular fat content is not expected to impair pig health,
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Page 2 of 15it might have consequences on muscle lipid metabolism
that need to be determined. Moreover, given the particu-
larly high intramuscular fat content of Duroc pigs, they
represent an interesting animal model to study the
changes in gene expression that are produced in response
to increased fat deposition. We have evaluated the muscle
transcriptomic profiles of Duroc pigs displaying diver-
gent fatness phenotypes to gain new insights into these
fundamental questions.
Methods
Biological samples
Animals came from a commercial Duroc line used for the
production of fine quality cured ham and characterised
by a high intramuscular fat content. This commercial line
was being selected for a compound objective including
prolificacy, growth, intramuscular fat and leanness. A
population of 350 half-sib castrated males was generated
by mating five males with 400 females and selecting one
male offspring per litter, as described in Gallardo et al.[7].
A total of 70 phenotypes on growth, fatness, feed effi-
ciency and carcass and meat quality traits were recorded
in these animals, including weight, daily food intake, fat
deposition measures, and intramuscular fat content and
fatty acid composition (C:12-C:22 interval) of gluteus
medius and longissimus thoracis et lumborum muscles
[8]. In addition, serum total cholesterol, HDL- and LDL-
bound cholesterol and triglycerides were measured in
two blood samples taken at 45 and 190 days of age as
described in Gallardo et al. [7]. At slaughter, samples of
muscle from the gluteus medius were collected, snap fro-
zen in liquid nitrogen and stored at -80°C until analysed.
The experimental procedures, traits recording and blood
sampling were approved by the Ethical Committee of the
Institution (IRTA - Institut de Recerca i Tecnologia
Agroalimentàries).
Experimental design
With the aim of mimicking to some extent the effects of
divergent selection for two extreme fatness phenotypes, a
principal component analysis (PCA) that allowed synthe-
sising global phenotypic variability recorded in our popu-
lation was performed by means of the PRINCOMP
procedure of SAS (SAS Inst. Inc., Cary, NC). Several pre-
liminary analyses considering the whole set of lipid-
related phenotypes (including muscle content of individ-
ual fatty acids and several carcass fat measures) allowed
us to detect traits with either low variability or displaying
high correlations with other ones. These traits did not
contribute significantly to the phenotypic variance
explained by the principal components and were dis-
carded from further analyses. Finally, a subset of 13 mea-
sured traits (Table 1) were considered as the most
relevant descriptors of total population variability related
to lipid metabolism and lipid content of gluteus medius
muscle, and were included in the PCA. The first principal
component (see Table 1 for coefficients) explained 30.7%
of the global phenotypic variance of these traits and was
used to rank the animals. Pigs from the extremes of the
ranking were selected to create the HIGH (n = 35) and
LOW (n = 35) groups, as described in Figure 1. More
details about the PCA results and phenotypic variation of
the HIGH and LOW groups with divergent phenotypes
for fatness traits is provided in the results section.
RNA isolation and microarray hybridisation
Samples of gluteus medius were ground with mortar and
pestle in liquid nitrogen and homogenised with a
mechanical rotor. RNA was isolated by the acid phenol
method [9] using the RiboPure kit (Ambion, Austin, TX).
RNA was quantified in a Nanodrop ND-1000 spectro-
photometer and checked for purity and integrity in a Bio-
analyzer-2100 (Agilent Technologies, Inc., Santa Clara,
CA).
Seventy total RNA samples from the HIGH (n = 35)
and LOW (n = 35) groups were individually hybridised on
GeneChip Porcine Genomic arrays (Affymetrix, Inc.,
Santa Clara, CA). A randomised list of the samples was
generated to assign hybridisation order to the 70 RNA
samples. Total RNA was used to synthesize double
stranded cDNA using the One Cycle cDNA Synthesis Kit
(Affymetrix, Inc.) which incorporates a T7 RNA poly-
merase promoter. Biotin-labelled antisense cRNA was
obtained using the same kit starting with 5 μg of total
RNA and the oligo-(dT) primer 5'-GGCCAGTGAATTG-
TAATACGACTCACTATAGGGAGGCGG-(dT)24.
cRNAs were purified with the GeneChip Sample Cleanup
Module (Affymetrix, Inc.) and then 20 μg of cRNA were
fragmented at 94°C for 30 min in 40 μl of 40 mM Tris-
acetate pH 8.1, 100 mM KOAc, 30 mM Mg(OAc)2,
checked using the Bioanalyzer 2100 (Agilent Technolo-
gies, Inc.) and added to a hybridisation cocktail contain-
ing control oligonucleotide B2 (50 pM) and Eukaryotic
Hybridization controls (BioB, BioC, BioD, Cre) at 1.5, 5,
25 and 100 pM final concentration respectively from the
GeneChip Eukaryotic Hybridisation Control Kit
(Affymetrix, Inc.), herring sperm DNA (0.1 mg/ml) and
acetylated BSA (0.5 mg/ml). The GeneChip Porcine
Genome Array was equilibrated to RT and prehybridised
with 1× hybridisation buffer (100 mM MES, 1 M [Na+],
20 mM EDTA, 0.01% Tween 20) at 45°C for 10 min with
rotation. The hybridisation cocktail was heated to 99°C
for 5 min in a heat block, transferred to 45°C for 5 min,
added to the arrays and hybridised at 45°C for 16 hours
with rotation in the Affymetrix GeneChip Hyb Oven 640
(Affymetrix, Inc.). GeneChips were washed and labelled
with streptavidin phycoerythrin in the Fluidics Station
450 (Affymetrix, Inc.) using the protocol EukGE-WS2-v5
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in an Agilent G3000 GeneArray Scanner (Agilent Tech-
nologies, Inc.).
Quality control of expression data
The "Affy" and "Sympleaffy" packages from the Biocon-
ductor project [10] were used to implement a set of qual-
ity control metrics recommended by Affymetrix to assess
the quality of RNA samples and their subsequent label-
ling and hybridisation steps [11]. These include compari-
son of the background signal, intensity scaling factor,
percentage of genes called, and 3'/5' intensity ratio of con-
trol probes in all arrays. Quality control analysis per-
formed with raw intensity data resulted in the
identification of two arrays with problems in the labelling
efficiency of the 5' vs 3' control probes. Therefore, data
from these two arrays were discarded from further analy-
sis, reducing the number of data available to 68 arrays (34
per group).
Class comparison analysis on expression data
Data pre-processing, normalisation and class comparison
analysis were carried out with the BRB-ArrayTools soft-
ware version 3.7.1 [12], which is available online at http://
linus.nci.nih.gov/BRB-ArrayTools.html, as follows:
microarray data normalisation was performed using the
gcRMA algorithm, which corrects the intensity of each
probe by its GC content [13]; genes showing minimal
variation across the set of arrays were excluded from the
analysis, that is, only genes displaying more than 20% of
expression values over ± 1.5 times the median expression
of all arrays were used for further analysis. From the total
23937 spots of the array, 4299 spots passed these filtering
conditions. For each probe, expression fold-change was
calculated as the ratio between median values in both
groups.
Class comparison was performed with a dataset of 68
samples of gluteus medius from the HIGH (n = 34) and
LOW (n = 34) groups. A global two-group t-test with a
random variance model was performed. This type of t-
test is an improvement over the standard one-gene t-test,
as it permits sharing information about within-class vari-
ation among genes without assuming that all genes have
the same variance [14,15]. By using these variance esti-
mates, this method gains degrees of freedom over the
standard t-test, providing greater sensitivity with no loss
in specificity [14]. For each probe, the significance p-val-
ues of the group effect were calculated based on 100,000
random permutations, and the nominal significance level
Figure 1 Graphical plot of the first and second principal components summarising phenotypic variation in the Duroc population. Summary 
of phenotype variation on serum lipid, growth and fatness parameters in the Duroc pig population. Relative weight of considered variables and po-
sition of animals from the HIGH and LOW groups are represented in the graph. Abbreviations are defined in Table 1.
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Page 4 of 15of each univariate test was restricted to p < 0.01 [12,14].
Additionally, a multiple test correction was performed by
restricting the FDR to < 0.05 [16]. The significance level
of the whole experiment was also calculated by data per-
mutation: for each permutation, the p-values were re-
computed and the number of genes significant at the 0.01
level of the permutation p-value was annotated.
Gene Ontology-based analysis
We performed a functional categorization of our result-
ing list of differentially expressed genes using Gene
Ontology (GO) information. To annotate the probes in
the Affymetrix array we used the latest annotation file
available [17]. First, Database for Annotation, Visualiza-
tion and Integrated Discovery (DAVID, http://
david.abcc.ncifcrf.gov) was employed to explore func-
tional class scoring in the resulting gene list by means of
GO term enrichment analysis [18]. Significance levels
were calculated following a modification of Fisher's exact
test. A multiple testing-corrected p-value was also calcu-
lated using Benjamini and Hochberg algorithm [16], and
only GO terms with Benjamini-corrected p < 0.1 were
considered. DAVID was additionally used to explore the
biological pathways enriched in the resulting gene list,
using information from each individual gene and com-
puting a total over-representation value for each pathway
represented in the Kyoto Encyclopaedia of Genes and
Genomes (KEGG, http://www.genome.jp/kegg) and Bio-
Carta http://www.biocarta.com.
As a complementary approach, Ingenuity Pathway
Analysis, Ingenuity Systems (IPA, http://www.ingenu-
ity.com) bioinformatic tools were employed to explore
the distribution of differentially expressed genes in well
reported canonical signal transduction or metabolic
pathways integrating fold-change data from the microar-
ray experiment and gene-to-gene or protein-to-protein
interaction information generated from the literature
databases. In this approach, statistical significance of
pathway overrepresentation was established with respect
to a null distribution constructed by permutations.
Systems biology studies
We have used the Pathway Express program [19] to iden-
tify pathways affected by the list of genes differentially
expressed between groups. This program integrates
topological information regarding the position of genes
in the metabolic and gene signalling pathways defined by
KEGG and the multiple roles that these genes might have
depending on the pathway they belong to. This program
calculates a Perturbation Factor for each gene, which is
computed by normalising the expression ratio with infor-
mation about its topology in the pathway (i.e., number of
Table 1: Total population, HIGH and LOW group mean values ± standard error for the traits used in the selection index
Weight in PC1† Population n = 350 HIGH group n = 35 LOW group n = 35
Carcass traits
LW - Live weight (Kg) 0.218 122.08 ± 0.74 127.30 ± 1.94 111.94 ± 2.66
BFTiv - Backfat thickness (in vivo) (mm) 0.342 23.58 ± 0.26 27.26 ± 0.69 19.00 ± 0.64
BFT - Backfat thickness 3rd-4th ribs (mm) 0.200 38.31 ± 0.60 47.43 ± 1.84 32.49 ± 1.71
HFT - Ham fat thickness (mm) 0.328 25.71 ± 0.19 28.47 ± 0.41 20.94 ± 0.61
LEAN - Lean % -0.265 40.86 ± 0.24 38.26 ± 0.79 45.94 ± 0.71
Meat quality traits (gluteus medius)
IMF - % Intramuscular fat 0.304 5.17 ± 0.10 7.46 ± 0.39 3.58 ± 0.15
SFA - % Saturated fatty acids 0.276 36.46 ± 0.10 38.55 ± 0.25 34.65 ± 0.21
PUFA - % Polyunsaturated fatty acids -0.315 20.62 ± 0.32 14.37 ± 0.52 27.35 ± 0.81
MUFA - % Monounsaturated fatty acids 0.275 42.92 ± 0.27 47.08 ± 0.45 38.00 ± 0.80
Serum lipid levels - 190 days
CHOL - Total cholesterol (mg/dl) 0.335 125.15 ± 1.40 157.60 ± 5.02 104.03 ± 2.70
HDL - HDL-cholesterol (mg/dl) 0.285 51.66 ± 0.54 61.63 ± 1.27 43.26 ± 1.60
LDL - LDL-cholesterol (mg/dl) 0.266 63.12 ± 1.09 82.65 ± 4.70 50.58 ± 2.53
TG - Triacylglycerides (mg/dl) 0.101 51.37 ± 1.25 66.43 ± 4.46 47.66 ± 4.75
The weight of each trait in the first principal component (PC1) is also indicated.
†PC1 - weight of each trait in the first principal component.
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each pathway, Perturbation Factors from each individual
gene are combined to calculate an Impact Factor, which is
normalised according to the total number of genes in the
pathway [19]. The complete list of genes in the array was
used as a reference set in the analysis.
Quantitative real time PCR
Quantitative real time PCR (qPCR) was used to validate
relevant genes differentially expressed between the two
groups of animals with extreme values for lipid metabo-
lism traits. With this aim, a subset of the 10 most extreme
animals from each group was selected. Total RNA sam-
ples were retrotranscribed with random hexamers and
SuperScript III retrotranscriptase (Invitrogen, Carlsbad,
CA) following manufacturer's instructions. cDNA was
diluted 1:10 in DEPC-treated H2O prior to qPCR analy-
sis. Primers and TaqMan probes (Additional file 1) were
designed with the Primer Express software (Applied Bio-
systems, Foster City, CA) using pig sequences obtained
by performing a BLAST search with the array probe
sequence. For each gene, a standard curve was generated
by amplifying serial dilutions of a control ss-cDNA to
check for linearity between initial template concentration
and Ct values. Quantitative real-time PCR assays were
carried out in triplicate in an ABI-7500 device (Applied
Biosystems) in a final volume of 5 μl containing 1× Power
SYBRgreen Master mix (Applied Biosystems) and 200
nM of each primer. For the two reference genes (HPRT
and RPL32), PCR reactions contained 300 nM of each
primer, 200 nM TaqMan probe and 1× Universal Taqman
Master Mix (Applied Biosystems). The following thermal
profile was used for all reactions: 10 min at 95°C, 40
cycles of 15 s at 93°C and 1 min at 60°C, followed by a
quick denaturation at 95°C for 5 min plus a slow ramp to
30°C to generate a dissociation curve to control the speci-
ficity of the amplified product. In order to quantify and
normalise the expression data we used the ΔΔCt method
[20] using the mean Ct value from the two reference
genes and the Ct values for each test gene. For each gene,
expression values between groups were compared with a
t-test and differences were considered significant at p <
0.05. The correlation analysis between qPCR and
microarray expression data was performed using the
CORR procedure of SAS (SAS Inst. Inc.).
Results
Phenotypic variation in the two groups with highly 
divergent phenotypes for fatness traits
A principal component analysis was performed in order
to summarise the global variability of traits strongly
related to lipid deposition and composition. Figure 1 dis-
plays the relative weight of each variable in the two first
principal components, along with the relative position of
animals selected for the HIGH and LOW groups. The
first principal component explained 30.7% of total vari-
ability, whereas the second and following principal com-
ponents accumulated less than 16% of phenotypic
variability. The first principal component (Figure 1)
grouped several fatness (fat thickness) measures and
serum cholesterol values, together with intramuscular
fat, saturated and monounsaturated fatty acids content in
gluteus medius, while lean percentage and gluteus medius
polyunsaturated fatty acids content were closely located
at the other extreme of the axis. It is worth mentioning
that intramuscular fat, monounsaturated and saturated
fatty acids content were consistently grouped together in
the three first principal components, in concordance with
phenotypic correlations and physiological relationships
among them [21], whereas polyunsaturated fatty acids
always had an opposite relative weight. We finally used
the first principal component as a classification index to
rank all animals in the experiment (Table 1). Pigs at the
higher and lower 10% of the ranking were used to gener-
ate the HIGH (n = 35) and LOW (n = 35) groups. For all
traits, phenotypic means differed significantly between
groups and also with regard of the population mean
(Table 1). The highest differences were observed in traits
directly related to fatness and muscular fat characteris-
tics. At the top extreme of the ranking, the classification
index positioned animals with increased subcutaneous
and intramuscular fat deposition. These two traits are
important in the dry-cured ham manufacturing process.
Monounsaturated and polyunsaturated fatty acids per-
centages were weighted in opposite directions, thus
favouring HIGH group displaying higher oleic and lower
polyunsaturated fatty acid contents in the final product.
This is an advantageous feature because it reduces the
rancidity potential of meat.
Differential expression between HIGH and LOW groups
A total of 1060 probes were found differentially expressed
between animals from the HIGH vs LOW groups at a
nominal p < 0.01 and restricting the FDR to 0.05 (Addi-
tional file 2). A very high overall significance level of the
experiment was obtained (p < 10-7), confirming differ-
ences in the expression pattern of the gluteus medius
muscle of these two groups of animals. From the 1060
probes, most of them (n = 839) were overexpressed in the
HIGH group while only 221 showed higher expression
levels in the LOW group. Expression fold-change
between groups ranged from 0.38 (repressed in HIGH) to
5.58 (overexpressed in HIGH) and only 388 probes dis-
played more than 1.5-fold change between groups. The
actual range of fold-change values depends on the data
pre-processing and normalisation. Indeed, the most com-
monly used algorithms (MAS5, RMA and gcRMA) com-
press data in different ways, thus affecting the proportion
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greater or smaller ranges of expression intensities across
replicate values [14]. In this sense, we used here the
gcRMA algorithm which moderately compresses data,
less than RMA but more than MAS5. Since fold-change
ranges vary depending on the algorithm employed, estab-
lishing a cutting threshold of 1.5- or 2.0-fold as biologi-
cally significant is meaningless. Consequently, we used
the complete list of differentially expressed probes in the
subsequent analyses. From the list of 1060 probes, 10
were not annotated, 94 were assigned to EST or ORF
sequences, and 956 were assigned to genes (correspond-
ing to 836 single genes; Additional file 2). In a microarray,
some genes are represented by several probes to evaluate
the consistency of gene expression measurements. In our
study, 442 single genes showed differential expression for
the whole set of probes (100% of consistency across
probes), while for the remaining 394 single genes, only a
subset of the probes in the array were found to be differ-
entially expressed between groups. The microarray data
related to all samples have been deposited in the Gene
Expression Omnibus (GEO) public repository (GEO
accession number: GSE19275).
Ontological analysis of differentially expressed genes
GO term annotations were used to perform a functional
categorisation of the resulting list of genes generated in
the class comparison analysis. The three GO categories
(biological process, metabolic function and cell compo-
nent) were explored with DAVID bioinformatic tools for
overrepresentation of specific GO terms. Significant
results (at Benjamini-corrected p < 0.1) are summarised
in Additional file 3. The most relevant results were
obtained under the Biological Process category. Within
this category, the top of the list gathered several terms
related to "RNA processing", while spread over the list
there were a variety of general "metabolic process" terms.
Interestingly, four specific GO terms related to "lipid
metabolism" appeared in the middle of the list, evidenc-
ing that a substantial fraction of genes were directly asso-
ciated with traits under study.
Metabolic pathways and gene networks affected by the 
differentially expressed genes
The analysis of metabolic pathways and gene transactiva-
tion networks where the differentially expressed genes
play a prominent role is essential to extract biological
information and conclusions from a microarray experi-
ment. In order to extract most information from our
between-groups gene expression data, results from three
exploration tools were compared.
First, the IPA software was used to survey the pathways
overrepresented in our gene list. A total of 12 pathways
were above the significance threshold (Figure 2A). Strik-
ingly, the Antigen presentation pathway was the most sig-
nificant route. In addition, several gene transactivation
cascades involving the RXR factor were also included
(Figure 2A). Besides, the IGF-1 signalling pathway, which
determines the fat vs muscle growth, resulted very signif-
icant (p < 0.001) in this analysis. As regards the regulatory
networks (Figure 2B), several lipid metabolism-, energy
uptake- and muscle growth and function-related path-
ways were amongst the most relevant networks repre-
sented by the list of differentially expressed genes.
A second exploration tool, DAVID Functional Annota-
tion tool, identified none of the BioCarta pathways as
affected by the list of differentially expressed genes. In
contrast, 12 KEGG pathways (p < 0.1; Table 2) were iden-
tified and, remarkably, eight of them played a relevant
role in lipid metabolism or muscle and/or adipose tissue
differentiation (arrows in Table 2).
A third method, Pathway Express [19], was used to
explore the existence of signalling networks connecting
differentially expressed genes. A total of 19 pathways
were inferred from the list of genes with different mRNA
levels in both groups (p < 0.05; Table 3). Among these, we
found the 12 KEGG pathways previously described by
DAVID's Functional Annotation tool but with important
differences in the ranking of relevance. A KEGG diagram
showing genes in each pathway is presented in the Addi-
tional file 4A to H. Many of the significant pathways were
very relevant to the muscular and/or adipose physiology
(arrows in Table 3). Like in IPA, the pathway with the
highest impact factor was Antigen presenting and process-
ing, followed then by Phosphatidylinositol signalling and
Biosynthesis of unsaturated fatty acids. Regarding the lat-
ter, seven out of the 23 genes in this route, which encode
enzymes directly involved in the elongation and desatura-
tion of fatty acids, were differentially expressed between
the HIGH and LOW groups (Table 3, Additional file 4C).
Only one of them (GPSN2 - a reductase that participates
in the desaturation of long and very long chain fatty
acids) is overexpressed in the LOW group whereas the
other six have higher levels in the HIGH group. The Insu-
lin signalling and Type II diabetes pathways (Additional
file 4D and 4), which are deeply associated with glucose
metabolism, were differentially expressed in both groups.
Among genes that take part in (or are connected with)
the insulin signalling cascade, one should emphasise the
following groups, all of them expressed at higher levels in
the HIGH group: (1) mitogen-activated protein kinase
(AMPK), acetyl-coA carboxylase α (ACACA) and fatty
acid synthase (FASN) genes that have a lipogenic role; (2)
PKA and hormone-sensitive lipase (LIPE) genes which
display a lipolytic action; (3) TBC1 domain family, mem-
ber 1 gene (TBC1D1), which plays a role in the transloca-
tion of the glucose transporter 4 (GLUT4) from the
endoplasmic reticulum to the cell membrane in response
Cánovas et al. BMC Genomics 2010, 11:372
http://www.biomedcentral.com/1471-2164/11/372
Page 7 of 15
Figure 2 Functional categorisation analysis of the list of genes differentially expressed between the HIGH and LOW groups obtained with 
IPA. A: List of most significant pathways represented in the list of genes (p < 0.01). B: List of most significant networks affected by the joint effect of 
represented pathways (p < 0.01).
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Page 8 of 15Table 2: DAVID analysis of pathways significantly enriched in the list of differentially expressed genes
KEGG id KEGG pathway 
name
Genes (n) Genes Fold† p-value*
?01040 Polyunsaturated fatty 
acids biosynthesis
7 SCD, TECR, ELOVL5, ELOVL6, FASN, PTPLB, ACAA1 8.3046 0.00001
05222 Small cell lung cancer 15 LAMB1, PIK3CA, LAMA5, LAMA2, CYCS, BIRC3, MAX, PIK3R1, ITGB1, COL4A1, 
ITGAV, CKS1B, LAMC2, BIRC4, RXRG
3.2728 0.0001
04612 Antigen processing 
and presentation
12 HSPA2, HSPA4, HLA-A, PSME1, HSP90AA1, TAPBP, HLA-DRA, B2M, HLA-G, 
CD74, NFYA, HLA-DMB
2.8473 0.0027
04510 Focal adhesion 21 PIK3CA, LAMB1, LAMA5, VEGFA, LAMA2, RAP1A, COL5A3, BIRC3, PIK3R1, 
ITGB1, IGF1R, COL4A1, ITGB3, THBS4, ITGAV, CAV1, LAMC2, EGFR, BIRC4, 
ROCK1, ROCK2
2.0031 0.0034
?04910 Insulin signalling 
pathway
15 PIK3CA, ACACA, PPARGC1A, RHOQ, EIF4E, LIPE, PIK3R1, PRKAR2B, IRS2, 
PPP1R3B, FASN, SORBS1, PRKAB2, IRS1, PRKAG2
2.1248 0.0097
?03320 PPAR signalling 
pathway
9 SCD, OLR1, FABP4, PPARG, ADIPOQ, ACAA1, RXRG, PPARD, SORBS1 2.3727 0.0334
?04512 ECM-receptor 
interaction
10 LAMB1, LAMA5, THBS4, ITGAV, LAMA2, COL5A3, LAMC2, ITGB1, COL4A1, 
ITGB3
2.1570 0.0396
?04070 Phosphatidylinositol 
signalling system
9 PIK3CA, ITPR1, DGKZ, SYNJ1, PLCD4, FN3K, PIK3R1, PIK3C2A, DGKG 2.2479 0.0444
04150 mTOR signalling 
pathway
7 ULK2, PIK3CA, VEGFA, EIF4E, PIK3R1, ULK3, RICTOR 2.6054 0.0488
?04930 Type II diabetes 
mellitus
6 PIK3CA, IRS2, CACNA1C, ADIPOQ, PIK3R1, IRS1 2.5309 0.0844
?04920 Adipocytokine 
signalling pathway
8 IRS2, PPARGC1A, ADIPOQ, ADIPOR2, RXRG, IRS1, PRKAB2, PRKAG2 2.0802 0.0862
?04350 TGF-beta signalling 
pathway
9 BMP5, FST, THBS4, CUL1, ZFYVE16, TGFB2, ROCK1, SMAD5, ROCK2 1.8982 0.0978
†Fold enrichment of the KEGG pathways in the list of differentially expressed genes with regard to the background dataset; *p-value from Fisher's 
exact test. Arrows indicate pathways relevant to muscle/adipose tissue function.
to the insulin signal; and (4) peroxisome proliferator-acti-
vated receptor-γ coactivator 1 gene (PPARGC1A), an
adapter of the PPAR family of nuclear receptors, which
takes part in the transactivation of effector genes. In addi-
tion, it is worth to mention the differential expression of
the insulin receptor substrate 2 (IRS2) gene, first effector
downstream the insulin receptor. The effect on this sub-
strate is, therefore, directly transmitted to the rest of the
cascade.
The PPAR signalling pathway is one of the most rele-
vant routes during the process of adipocyte tissue devel-
opment, differentiation and activation of lipogenesis
(Additional file 4F). In the HIGH group we observed
increased mRNA levels of peroxisome proliferator-acti-
vated receptor δ (PPARD), γ (PPARG) and PPARGC1
while retinoid × receptor γ (RXRG) mRNA was downreg-
ulated. Moreover, the fatty acid binding protein 4
(FABP4) gene, a key player in the uptake of fatty acids,
exhibited higher mRNA levels in pigs of the HIGH group.
We also observed changes in the Adipocytokine signal-
ling pathway (Additional file 4G), particularly the mRNA
levels for ADIPOQ and adiponectin receptor 2
(ADIPOR2) were overexpressed in the HIGH group
(Additional file 4G) alongside with AMPK, RXRG,
PPARGC1A which indirectly affect the oxidation and
degradation of lipids in mitochondria through the carni-
tine palmitoyltransferase 1 gene (CPT1).
Two other pathways related to myocyte growth and dif-
ferentiation happened to be affected by the genes differ-
entially expressed between the HIGH and LOW groups.
First, the Extracellular matrix interaction pathway (Addi-
tional file 4H), which consists of a complex mixture of
structural and functional macromolecules (integrins,
proteoglycans, CD36, and other cell-surface-associated
components) with an important role in tissue and organ
morphogenesis and function [22]. From the genes that
take part in this pathway, we have identified expression
changes in α and β integrins, collagen and transforming
growth factor β (TGFβ) receptor genes. The second path-
way of interest was the TGFβ signalling route (Additional
file 4I) that participates in many cellular processes like
cell differentiation, proliferation and apoptosis. The
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Page 9 of 15TGFβ factor differentially expressed in the HIGH group
was TFGB2, whose role in the muscular or adipose tissue
development is not currently known.
Quantitative PCR validation of microarray results
The information relative to the gene ontology and path-
ways analysis was used to select 31 genes with a relevant
function in muscle and adipose physiology and lipid
metabolism (Additional file 5). The selection was also
based on literature and database searches for each indi-
vidual gene from the resulting a 879-genes list. In this
way, genes functionally related to muscle and fat cell
metabolism were selected to be validated by qPCR in a
subset of 10 animals from each group. In order to confirm
the probe annotation information, we first conducted a
BLAST search with the sequences used by Affymetrix to
generate the microarray probes. Three of the 31 probes
analysed were wrongly annotated and were, therefore,
excluded from further analysis. Efficient qPCR assays
were established for 25 out of the 28 remaining genes. For
all 25 genes (Table 4), the fold-change ratios between
HIGH and LOW groups were consistent in both assays
except for TBC1D1 and RXRG genes. In addition, in most
cases the expression ratios were higher in the qPCR
experiment than in microarray based analyses (Figure 3)
[23]. A high level of correlation (ranging from 0.48 to
0.96; p < 0.05) was observed between qPCR and Affyme-
trix microarray data for all genes except for TBC1D1 and
RXRG (Table 4).
All together, validation of microarray data by qPCR
revealed a high correspondence between both analyses,
confirming differential expression for 19 out of 25 genes
tested (p < 0.05). The significance level of the differences
between HIGH and LOW groups tended to be greater in
the microarray experiment, which might be due to the
higher background noise of the qPCR assay.
Discussion
The ultimate goal of selection is to fix a set of genotypes
that are advantageous from a production, economic or
nutritional point of view [24]. This might involve signifi-
cant changes in the physiology and metabolism of indi-
viduals under selection [25]. In pigs, traditional selection
has been focused to obtain leaner individuals but this
practice has had detrimental consequences on meat qual-
ity due to a reduction in intramuscular fat and a parallel
increase in polyunsaturated fatty acids [26], which are
highly susceptible to lipid oxidation [1]. Genetic and phe-
notypic correlations suggest that selection for higher
intramuscular fat (as a way to improve the palatability
and juiciness of meat) might increase fatness, serum lip-
ids and meat monounsaturated fatty acids and saturated
fatty acids contents [3]. In summary, selection for
increasing either leanness or intramuscular fat might lead
to two extreme phenotypes with divergent muscular met-
abolic profiles. We have been able to capture these two
phenotypic classes (HIGH and LOW groups) in a Duroc
commercial population that had been selected aiming to
increase intramuscular fat while maintaining carcass fat-
ness. The utilization of a PCA approach seems to have
been particularly efficient in detecting individuals that
are different for a global multitrait phenotype rather than
for a particular trait, as supported by the high overall sig-
nificance achieved in the differential expression experi-
ment. In the next sections we will discuss changes of
muscle gene expression that are associated with each one
of these composite phenotypes and their physiological
and metabolic implications.
Lipid metabolism
We have observed significant changes in the expression
of genes and pathways related to lipid metabolism (Tables
4 and Additional file 1). Fatty acid uptake genes such as
FABP4 and Apolipoprotein E (APOE) were upregulated in
the HIGH group. Fatty acid-binding proteins are small
cytosolic molecules that bind saturated and unsaturated
fatty acids. Mice where FABP4 expression has been abol-
ished are less susceptible to develop insulin resistance
and dislipidemias [27]. APOE remove chylomicron rem-
nants from circulation by interacting with low density
lipoprotein receptor (LDLR), LDLR-related protein 1
(LRP1) and other receptors thus favouring lipid deposi-
tion [28]. In fact, APOE knockout mice have less body fat
stores, smaller adipocytes and they are more resistant to
diet-induced obesity [28]. This increased expression of
fatty acid uptake molecules might represent a compensa-
tory response to the higher levels of serum lipids in the
HIGH group (Table 1). De novo lipogenesis genes (i.e.
ACACA, FASN) were also upregulated (Table 4 and Addi-
tional file 1). Malonyl-CoA, a powerful inhibitor of the
carnitine/palmitoyl shuttle system for fatty acid β-oxida-
tion and the substrate of FASN [29], is synthesised by
ACACA, so increased expression of this enzyme might
lead to an accumulation of muscle fat stores [29]. Two
other genes promoting lipid deposition, stearoyl CoA
desaturase (SCD) and diacylglycerol O-acyltransferase 2
(DGAT2), displayed an increased expression in the HIGH
group (Tables 4 and Additional file 1). SCD plays a key
role in the synthesis of monounsaturated fatty acids
which, in turn, regulate other fundamental components
of lipid metabolism such as sterol regulatory element-
binding protein (SREBP) and MAPK. In human, a high
SCD activity is associated with a metabolic state favoring
hepatic triglyceride accumulation and expansion of adi-
pose triglyceride stores [30]. In consequence, a higher
SCD expression in the muscle might partition fatty acids
towards storage rather than to oxidation [30]. DGAT2 is
the main enzyme involved in the synthesis of triglycerides
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Page 10 of 15and its increased expression might also favour lipid stor-
age [31]. Similarly, CCAAT/enhancer-binding protein δ
(CEBPD) and PPARG, whose expression is upregulated in
HIGH pigs, are transcription factors which promote fat
deposition [32,33]. This pattern of gene expression sug-
gests that the increased lipid deposition of HIGH pigs is
the result of several metabolic processes rather than the
consequence of a single biochemical event.
There is substantial evidence that the aforementioned
genes are differentially expressed in adipose tissue cells
and myocytes (Novartis Gene Expression Atlas, http://
biogps.gnf.org/#goto=welcome), while their status in
intramuscular adipocytes remains largely unknown [34].
An obvious and unavoidable limitation of our experiment
was that we were unable to separate myocytes and intra-
muscular adipocytes before isolating RNA. The influence
of this feature on our expression data is difficult to evalu-
ate. Intramuscular fat (LOW: 3.5%, HIGH: 7.5%) comes
from two different sources: small adipocytes localized
between muscular fibres and lipid droplets contained
within myocytes [34]. This means that the percentage of
intramuscular adipocytes cannot be simply calculated
based in intramuscular fat content. Moreover, gene
expression profile of intramuscular adipocytes is mostly
unknown, although there is compelling evidence that in
pigs is clearly different from that of subcutaneous and
perirenal adipocytes [34,35]. For instance, FASN, PPARG
and LIPE mRNAs are 600, 200 and 800 times less
expressed in intramuscular than in subcutaneous adipo-
cytes of 160-days-old pigs [34]. Proteomic studies have
also evidenced that lipogenic, lipolytic, glycolytic and
fatty acid oxidation pathways are clearly downregulated
in intramuscular adipocytes when compared with fat cells
from other depots [35]. These results suggest that differ-
ences in the proportion of intramuscular adipocytes
between HIGH and LOW groups might have a minimum
impact on the patterns of muscle gene expression. This
interpretation is strongly supported by the fact that gene
expression changes detected in our experiment are very
consistent with a plethora of data obtained in human
indicating that fatty acid uptake, lipogenesis and triglyc-
eride synthesis genes are upregulated in the muscle cells
of obese individuals [5].
Fat accumulation in the skeletal muscle might be quite
harmful for this tissue as well as for the whole organism
[6,36]. Obese sedentary individuals have an increased
rate of lipid peroxidation and higher levels of certain lipid
metabolites, such as diacylglycerol, ceramides and long-
Table 3: Pathway Express analysis of metabolic pathways and gene networks significantly affected by differentially 
expressed genes
KEGG pathway-id KEGG pathway name IF† input/pathway genes pathway genes on chip p-value*
04612 Antigen processing and presentation 61.066 15/88 45 1.87E-25
?04070 Phosphatidylinositol signalling system 18.350 10/77 60 2.08E-07
?01040 Biosynthesis of unsaturated fatty acids 10.791 7/23 18 2.43E-04
05222 Small cell lung cancer 8.686 14/87 71 1.64E-03
04510 Focal adhesion 7.117 20/199 169 6.58E-03
05332 Graft-versus-host disease 6.966 6/42 22 7.52E-03
?04910 Insulin signalling pathway 6.430 16/138 114 1.20E-02
05310 Asthma 6.323 5/30 17 1.31E-02
04520 Adherents junction 5.957 6/75 69 1.80E-02
04514 Cell adhesion molecules (CAMs) 5.952 13/133 95 1.81E-02
05330 Allograft rejection 5.813 6/38 26 2.04E-02
?04930 Type II diabetes mellitus 5.556 6/44 33 2.53E-02
?04512 ECM-receptor interaction 5.211 10/87 72 3.39E-02
05320 Autoimmune thyroid disease 4.955 6/53 31 4.20E-02
04940 Type I diabetes mellitus 4.955 6/44 31 4.20E-02
04150 mTOR signalling pathway 4.932 7/51 42 4.28E-02
?04920 Adipocytokine signalling pathway 4.779 8/72 64 4.66E-02
?03320 PPAR signalling pathway 4.684 9/69 61 4.75E-02
?04350 TGF-beta signalling pathway 4.662 9/89 74 4.95E-02
†Impact Factor; *p-value from Fisher's exact test. Arrows indicate pathways relevant to muscle/adipose tissue function.
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Page 11 of 15chain fatty acids in the myocyte cytoplasm [6]. Both fea-
tures are well known to promote the development of
insulin resistance [6]. In this sense, animals in the HIGH
group had upregulated levels of lipin 1 (LPIN1) mRNA,
which induces the synthesis of diacylglycerol from phos-
phatidic acid [37,38], and of elongation of very long chain
fatty acids-like 5 and 6 (ELOV5, ELOVL6) mRNA which
promote the elongation of fatty acids [39]. These genes
might increase the production of metabolites that are
well known to have negative effects on insulin metabo-
lism.
In this context, it might be argued that selection for
increasing intramuscular fat content might have detri-
mental consequences on glucose and lipid homeostasis in
the skeletal muscle. However, we have obtained substan-
tial evidence of the activation of pathways which might
counteract the accumulation of intracellular lipids (Table
4 and Additional file 1). In this way, increased LIPE and
CES3 mRNA expression were detected in the HIGH
group. These two lipases are deeply involved in the
hydrolysis of triacylglycerols [37]. The remarkable
expression differences observed in the HIGH and LOW
groups (about 3-4 fold in the qPCR analysis) cannot be
explained in terms of adipocyte abundance, but as the
consequence of a physiological change in muscle cells. In
this regard, the simultaneous upregulation of genes with
lipogenic (ACACA, FASN, SCD, DGAT2) and lipolytic
(LIPE, CES3) actions would involve the existence of a
futile cycle where triacylglycerols are continuously
degraded and resynthesised. It has been suggested that,
ultimately, intramuscular fat accumulation results from a
balance between uptake, synthesis and degradation of
triglycerides, rather than the upregulation of a single
pathway [40]. Our results seem to point out also in this
direction. Moreover, the upregulated LIPE and CES3
mRNA expression might have a protective effect in the
muscle cell by degrading intracellular lipids (such as dia-
cylglycerol) which might otherwise inhibit insulin signal-
ling. Another line of defence against lipid overload would
be featured by ADIPOQ, PPARD and PPARGC1 mRNAs,
which are upregulated in the HIGH group and promote
the catabolism of fatty acids. PPARGC1A is an adapter of
nuclear receptors which plays a central role in the modu-
lation of gene transactivation in several signalling routes,
such as insulin, adipokines and bioactive lipids [41]. In
the skeletal muscle, PPARGC1A avoids the development
of insulin-resistance by increasing the proportion of oxi-
dative fibres and stimulating mitochondrial biogenesis,
two features that promote fatty acid oxidation [42].
PPARD, a transcription factor primarily expressed in
muscle cells, also enhances fatty acid oxidation and
energy expenditure [33]. Finally, adiponectin binding to
its receptor also stimulates fatty acid oxidation and
decreases triglyceride storage in muscle, which may
explain, in part, the insulin-sensitising effect of this hor-
mone [43]. This process relies on the activation of
AMPK, a master regulator of cellular energy balance [43].
Activation of AMPK, in turn, depends partly on a phos-
pholipase C/Ca2+ Ca2+/Calmodulin-dependent protein-
kinase kinase-dependent pathway [44], a feature that
agrees well with our observations that phospholipase C
and calmodulin 2 mRNA are upregulated in the HIGH
group. Taken together, these results suggest that genes
activating the catabolism of fatty acids are upregulated in
Figure 3 Comparison of microarray and qPCR expression ratios (HIGH vs LOW groups) for the list of selected genes.
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Page 12 of 15the HIGH pìgs, although we have not found direct evi-
dence that genes integrated in the β-oxidation pathway
are differentially expressed in the HIGH and LOW
groups. Probably, ADIPOQ and PPARD exert their action
by introducing post-translational modifications in the β-
oxidation enzymes rather than modifying their levels of
expression. Finally, it is worth mentioning that our find-
ings do not agree with the observation that, in human,
fatty acid oxidation is reduced in obese individuals [5].
Insulin signalling and glucose metabolism
We have detected differential expression of genes related
to the insulin signalling pathway between the HIGH and
LOW groups. MADS-box transcription enhancer factor 2
polypeptide A (MEF2A, overexpressed in the HIGH
group) is abundantly expressed in muscle cells and it
binds to the promoter of the GLUT4 gene upregulating
its expression and glucose uptake [45]. Interestingly, insu-
lin receptor substrate 2 (IRS2), one of the two major insu-
lin receptor substrates, was also upregulated in the HIGH
group. Impaired function of IRS2 has been related to a
defective activation of phosphoinositide 3-kinase (PIK3),
a reduction in glucose uptake and insulin resistance in
certain studies [46] but not in others [47]. It is also worth
mentioning that we have found that PIK3 regulatory sub-
unit 1 (PIK3R1) and PIK3 class 2 alpha polypeptide
Table 4: Validation of microarray expression data by quantitative real-time PCR for 25 selected genes
GENE MICROARRAY qPCR Correlation
n = 68(34H vs 34L) n = 20(10H vs 10L)
Ratio† p-value Ratio† p-value r* p-value
ACACA  1.42 0.003 2.23 0.047 0.77 0.0002
ADIPOR2  1.39 0.001 1.49 0.354 0.59 0.0108
AGPAT2  0.73 0.01 0.44 0.043 0.60 0.0099
APOE  1.61 0.001 5.24 0.017 0.73 0.0006
CEBPD  1.24 0.004 1.05 0.078 0.69 0.0016
CES3  2.1 0.000003 3.41 0.008 0.83 < 0.0001
DGAT2  2.68 0.001 1.91 0.048 0.83 < 0.0001
ELOVL6  3.04 0.005 3.31 0.042 0.88 < 0.0001
FABP4  1.32 0.0002 2.33 0.037 0.92 < 0.0001
FASN  3.09 0.0008 2.54 0.046 0.88 < 0.0001
IGFBP5  0.68 0.0007 0.50 0.025 0.83 < 0.0001
IRS2  1.31 0.001 4.1 0.012 0.53 0.0231
LIPE  4.21 0.000002 3.91 0.001 0.76 0.0002
LPIN1  1.23 0.008 1.68 0.005 0.68 0.0018
MEF2A  1.37 0.0002 1.68 0.037 0.63 0.0051
NPC1  1.4 0.00006 3.69 0.018 0.48 0.0437
PIK3C2A  1.54 0.009 2.98 0.021 0.68 0.0020
PIK3R1  0.72 0.01 0.70 0.020 0.48 0.0424
PPARD  1.28 0.008 1.57 0.021 0.53 0.0248
PPARG  1.06 0.005 2.31 0.041 0.69 0.0016
PPARGC1A  2.38 0.004 1.57 0.152 0.96 < 0.0001
RXRG  0.68 0.002 1.12 0.621 -0.26 0.2911
SCD  3.07 0.004 4.04 0.156 0.96 < 0.0001
TBC1D1  1.17 0.0002 0.98 0.552 -0.16 0.5287
VEGFA  1.26 0.009 1.69 0.032 0.48 0.0444
Expression ratios and p-values are indicated for both assays and correlation coefficients between qPCR and microarray results are also shown.
H = HIGH group; L = LOW group; †Expression ratios between H and L groups; *correlation coefficients between qPCR and microarray results; 
in bold, genes whose difference in expression between groups has been validated by qPCR. Arrows up and down indicate gene 
overexpression and downregulation in the HIGH group, respectively.
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tively. Free, monomeric PIK3R1 can act as a negative reg-
ulator of PIK3 signalling downstream the insulin and
IGF1 receptors by competing with the PIK3R1/PIK3C
heterodimer for binding to tyrosine-phosphorylated IRS1
[48], while PIK3C2A is a subunit of PIK3. As a whole, pigs
of the HIGH group, which are fatter than their LOW
counterparts, show an mRNA profile compatible with an
increased glucose uptake. This does not necessarily mean
that the functionality of the molecules involved in this
pathway is identical in both groups, because we have not
evaluated post-translational changes, which are known to
have a critical impact on their activity [49]. At most, we
can affirm that glucose uptake and insulin signalling
pathways are not downregulated in the gluteus medius
muscle of HIGH pigs. This observation agrees very well
with the fact that de novo lipogenesis, which can use glu-
cose as a substrate, is upregulated in this group.
Immunity
The most striking difference amongst the HIGH and
LOW groups was that expression of antigen-presenting
molecules was downregulated in the former (Additional
file 4A). Interestingly, a significant reduction in the
expression levels of genes related to the immunity in
muscles from chickens selected for fat content has also
been described in other microarray studies [50]. A possi-
ble mechanism explaining our results would be related to
the increased expression of the adiponectin receptor 2 in
the muscle cells of HIGH pigs, which increases the syn-
thesis of the antiinflammatory cytokine interleukin (IL)
10, inhibits the synthesis of proinflammatory cytokines,
such as IL1β, IL6 and tumor necrosis factor (TNF), and
activates AMPK, a kinase that can disrupt NFκB tran-
scriptional activation, resulting in downregulation of
MHC expression [51]. Stearoyl CoA desaturase overex-
pression has also been reported to have antiinflammatory
activity through the conversion of palmitate to oleate
[52].
Muscle growth and differentiation
We have observed an upregulation of the TGFB2 and
TGFBR3 mRNAs in the HIGH group (Additional file 2
and 4I). The TGFβ signalling pathway participates in
many cellular processes like cell differentiation, prolifera-
tion and apoptosis. In the skeletal muscle, TGFβ is a pow-
erful inhibitor of the muscular proliferation and
regeneration from satellite cells [53]. For instance, myo-
statin, which is upregulated by TGFB1, inhibits muscular
proliferation [54]. Inactivation of this gene produces an
excessive growth of the muscular tissue that results in the
"double muscle" phenotype observed in Blue Belgian or
Asturiana cattle [55]. Moreover, transforming growth fac-
tor β molecules are positive regulators of extracellular
matrix proteins expression [56]. In this sense, we have
detected increased mRNA levels of integrins α5 (ITGAV)
and β1 (ITGB1) as well as of several collagen molecules
(COL4A5, COL12A1, COL4A1, COL5A3). The ability of
satellite cells to successfully participate in growth and
repair of the skeletal muscle is influenced heavily by sur-
rounding extracellular matrix factors [56]. In this way, the
formation of multinucleated myotubes requires the
migration of myoblasts, a process regulated by integrins
that ensure the adhesion of these precursor cells to the
extracellular matrix [56]. Finally, it is worth mentioning
that we have detected increased mRNA levels of myo-
genic factors such as insulin growth factor-binding protein
5 (IGFBP5) and ADIPOR2. These findings might be bio-
logically significant because there are evidences that
some level of postnatal muscle growth, relying on the
activation, differentiation and proliferation of precursor
satellite cells, takes place in pigs [57].
Conclusions
We have examined the mRNA expression profile of mus-
cle samples obtained from pigs with extreme phenotypes
for several fatness parameters. The HIGH phenotype cor-
responded to pigs with high levels of intramuscular fat,
serum lipids and muscle saturated and monounsaturated
fatty acid content, while LOW pigs were leaner and
showed increased levels of muscle polyunsaturated fatty
acids. This approach allowed us to detect striking differ-
ences in the expression profile of both groups, with the
HIGH group showing upregulated mRNA levels of genes
related to lipogenesis, lipolysis and glucose uptake and
decreased levels of mRNAs encoding antigen-presenting
molecules. As a whole, our data suggest that selection for
increasing intramuscular fat content in pigs would not
lead to a disruption of the metabolic homeostasis of mus-
cle cells. An evident limitation of our experiment is that
mRNA concentrations are not necessarily a faithful
reflection of protein levels or activities. In this regard,
Maier et al. [58] have reported that correlations between
mRNA and protein levels are moderate (rP = 0.36) to high
(rP = 0.76), being influenced by gene-specific (protein
half-life, translation efficiency etc.) and technical factors.
In consequence data about post-translational changes
affecting protein activity or expression as well as informa-
tion about protein location within the cell would be
needed to fully understand how lipid deposition affects
muscle physiology in pigs [57].
Additional material
Additional file 1 Sequence of primer sets used to validate microarray 
results of selected genes by quantitative real-time PCR. Gene symbol 
and GenBank accession number for each pig gene are indicated. Putative 
exon location is based on human gene structure information.
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